Proposed S.B. No. 80
Session Year 2023
 


AN ACT CONCERNING THE SHORTAGE OF CERTAIN DRUGS PRESCRIBED TO TREAT TYPE II DIABETES.

To provide that the Commissioner of Consumer Protection may adopt regulations to restrict prescriptions and sales of Trulicity and Ozempic to persons diagnosed with type II diabetes until the shortage of such drugs in this state has, in the commissioner's opinion, abated.

Introduced by:
Sen. Kevin C. Kelly, 21st Dist.

 New today  2-4 days old  5 days & older
  View or Add Notes to SB-80

Add Notes to SB-80

Go To My Bills


This bill is in My Bills.
Do you wish to go to My Bills?

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 2/3/2023Public Hearing 02/07
 1/19/2023(GL)Reserved for Subject Matter Public Hearing
 1/12/2023Referred to Joint Committee on General Law

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.